Skip to content
Friday, October 16, 2026 Market moodNeutral−14.7
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Market mood−14.7
Breaking
TECHCRUNCH Replit’s CEO says the future of work is the ‘self-driving company’ Neutral FREIGHTWAVES DHL earmarks $450M for Eastern Europe logistics expansion Strong Bullish WSJ ECONOMY Bank of Japan Must Ensure Underlying Inflation Doesn’t Go Above 2%, Ueda Says Bearish THE VERGE The Sony Xperia 10 VI won’t be getting a promised update to Android 17 Neutral NORTHERN MINER From the Archives: The rise and fall of Quebec’s asbestos industry Bullish THE VERGE The first vibe-coded gun is here Neutral CBS NEWS American journalist injured in West Bank clashes Bearish CBS NEWS Iran says Strait of Hormuz will reopen if U.S. leaves region Strong Bullish DEFENSE NEWS Recap: Autonomy dominates the US Army’s 2026 conference in Washington Strong Bullish CNBC TOP STORIES Europe's answer to SpaceX pops 19% as Ukraine's Starshield limits raise concerns  Bullish FOX NEWS US Suspected Florida Publix slasher walked free from court months earlier despite victim war… Pessimistic NEW YORK TIMES BUSINESS When Will the Fed Move on Rates? Bearish FOREIGN POLICY Uruguay Bucks Regional Migration Trend Neutral THE VERGE Surface Laptop Ultra review: a different kind of MacBook Pro Neutral THE VERGE The iPhone Duo is now available to preorder at $1,999 Neutral DEFENSE NEWS Blood supplies, autonomous systems shape US Army’s Indo-Pacific combat care plans Neutral CNBC TOP STORIES Tesla unveils long-delayed Roadster, showing off its flying-car ambitions Neutral FOX NEWS US Bystander fatally shoots suspected teen gunman in deadly elementary school shooting and m… Bearish CONSTRUCTION NEWS UK Higgins Homes trial: slinger tells jury of moment bricks fell, fatally injuring mum Optimistic CONSTRUCTION NEWS UK Farrans sank into loss in final year before acquisition Pessimistic TECHCRUNCH Replit’s CEO says the future of work is the ‘self-driving company’ Neutral FREIGHTWAVES DHL earmarks $450M for Eastern Europe logistics expansion Strong Bullish WSJ ECONOMY Bank of Japan Must Ensure Underlying Inflation Doesn’t Go Above 2%, Ueda Says Bearish THE VERGE The Sony Xperia 10 VI won’t be getting a promised update to Android 17 Neutral NORTHERN MINER From the Archives: The rise and fall of Quebec’s asbestos industry Bullish THE VERGE The first vibe-coded gun is here Neutral CBS NEWS American journalist injured in West Bank clashes Bearish CBS NEWS Iran says Strait of Hormuz will reopen if U.S. leaves region Strong Bullish DEFENSE NEWS Recap: Autonomy dominates the US Army’s 2026 conference in Washington Strong Bullish CNBC TOP STORIES Europe's answer to SpaceX pops 19% as Ukraine's Starshield limits raise concerns  Bullish FOX NEWS US Suspected Florida Publix slasher walked free from court months earlier despite victim war… Pessimistic NEW YORK TIMES BUSINESS When Will the Fed Move on Rates? Bearish FOREIGN POLICY Uruguay Bucks Regional Migration Trend Neutral THE VERGE Surface Laptop Ultra review: a different kind of MacBook Pro Neutral THE VERGE The iPhone Duo is now available to preorder at $1,999 Neutral DEFENSE NEWS Blood supplies, autonomous systems shape US Army’s Indo-Pacific combat care plans Neutral CNBC TOP STORIES Tesla unveils long-delayed Roadster, showing off its flying-car ambitions Neutral FOX NEWS US Bystander fatally shoots suspected teen gunman in deadly elementary school shooting and m… Bearish CONSTRUCTION NEWS UK Higgins Homes trial: slinger tells jury of moment bricks fell, fatally injuring mum Optimistic CONSTRUCTION NEWS UK Farrans sank into loss in final year before acquisition Pessimistic
Bezinga News · May 7, 2026 2:44 AM EDT Markets

Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED)

(Editor’s note: This story has been updated to include NAGE stock movement) Niagen Bioscience (NASDAQ:NAGE), the maker of anti-ageing supplements used by longevity entrepreneur Bryan Johnson, reaffirmed its 2026 sales growth outlook on Wednesday, after reporting first-quarter results that showed steady revenue gains and expanding investments into new product categories. Shares of the company dropped over 7% in after…

Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED)
Image Bezinga News

AI brief

Pulse reads the full article
What happened
Why it matters
What to watch

Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.

Sign in to read the brief
● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE